NO donors with anticancer activity

Bibliography

• IGNARRO LJ: Nitric oxide: a unique endogenous signaling molecule in vascular biology. Angew. Chem. Int. Ed. Eng. (1999) 38:1882–1892.
   Web of Science ®Google Scholar
• •Excellent review.
   Google Scholar
• FURCHGOTT RF: Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Angew Chem. Int. Ed Eng. (1999) 38:1870–1880.
   Web of Science ®Google Scholar
• •Excellent review.
   Google Scholar
• MONCADA S, PALMER RIVI, HIGGS EA: Nitric oxide physiology, patho-physiology and pharmacology. Pharmacal Rev (1991) 43:109–142.
   PubMed Web of Science ®Google Scholar
• TOMASIAN D, KEANEY JF, VITA JA: Antioxidants and the bioactivity of endothelium-derived nitric oxide. Cardiovasc. Res. (2000) 47:426–435.
   PubMedGoogle Scholar
• BATTINELLI EM, LOSCALZO J: Nitric oxide and platelet-mediated hemostasis. In: Nitric oxide cardiovascular system. Loscalzo J, Vita JA (Eds), Humana Press, Inc., Totowa, NJ, USA (2000):123–138.
   Google Scholar
• BRENNAN PA: The action and interactions of nitric oxide in solid tumor. Eur. I Surg. °mai (2000) 26:434–437.
   Google Scholar
• GRISHAM MB, JOURD'HEUIL D, WINK DA: Nitric oxide. I. Physiological chemictry of nitric oxide and its metabolites: implications in inflammation. Am. Physiology (1999) 276:G315–321.
   Google Scholar
• CHRISTOPHERSON KS, BREDT DS: Nitric oxide in excitable tissues: physiological roles and disease. I Chit. Invest. (1997) 100:2424–2429.
   Google Scholar
• BREDT DS: Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Rad. Res. (1999) 31:577–596.
   PubMed Web of Science ®Google Scholar
• NATHAN C, XIE QW: Nitric oxide synthases: roles, tolls, and controls. Cell (1994) 78:915–918.
   PubMed Web of Science ®Google Scholar
• ALDERTON WK, COOPER CE, KNOWLES RG: Nitric oxide synthases: structure, function and inhibition. Biochem. (2001) 357:593–615.
   Google Scholar
• AL-SNDONI H, FERRO A: S-nitrosothims: a class of nitric oxide-donor drugs. CM]. Sci (2000) 98:507–520.
   Google Scholar
• TSUKAHARA H, ISHIDA T, MAYUMI M: Gas-phase oxidation of nitric oxide: chemical kinetics and rate constant. Nitric Oxide (1999) 3(3):191–198,
   PubMed Web of Science ®Google Scholar
• RADI R, BECKMAN JS, BUSH KM, FREEMAN BA: Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. j Biol. Chem. (1991) 266(7):4244–4250.
   Google Scholar
• NATHAN C, HIBBS JB: Role of nitric oxide in macrophage antimicrobial activity. Curr. Opin. Microbial (1991) 3:65–70.
   Google Scholar
• BONFOCO E, KRAINC D, ANKARCRONA M, NICOTERA P, LIPTON SA: Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Nati Acad. Sci. USA (1995) 92:7162–7166.
   PubMed Web of Science ®Google Scholar
• MITROVIC B, IGNARRO LJ, VINTERS HV, AKERS MA, SCHMID I, UITTENBOGAART C: Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience (1995) 65:531–539.
   PubMed Web of Science ®Google Scholar
• WALKER MW, KINTER MT, ROBERTS RJ, SPITZ DR: Nitric oxide-induced cytotoxicity: involvement of cellular resistance to oxidative stress and the role of glutathione in protection. PedMtr. Res. (1995) 37:41–49.
   PubMed Web of Science ®Google Scholar
• DRAPIER JC, HIBBS JB: Murine cytotoxicactivated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. Chit. Invest. (1986) 78:790–797.
   Google Scholar
• FELDMAN PL, GRIFFITH OW, STUEHR DG: The surprising life of nitric oxide. Chem. Eng. News (1993) 71(50:26–38.
   Google Scholar
• LANCASTER JR: Nitric oxide in cells. American Scientist (1992) 80:248–259.
   Web of Science ®Google Scholar
• STUEHR DJ, NATHAN CF: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. j Exp. Med. (1989) 169:1543–1555.
   PubMed Web of Science ®Google Scholar
• YIM CY, MCGREGOR JR, KWON OD et al.: Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor. j Irnmunal (1995) 155:4382–4390.
   PubMed Web of Science ®Google Scholar
• BAYER PM, FUKUTO JM, BUGA GM, PEGG AE, IGNARRO LJ: Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. Biochem. Biophys. Res. Commun. (1999) 262:355–358.
   Google Scholar
• YANG W, ANDO J, KORENGA R, TOYO T, KAMIYA A: Exogenous nitric oxide inhibits proliferation of cultured vascular endothelial cells. Biochem. Biophys. Res. Commun. (1994) 203:1160–1167.
   PubMed Web of Science ®Google Scholar
• DIGIOVANNI J: Multistage carcinogenesisin mouse skin. Pharmacal Ther. (1992) 54:63–128.
   PubMed Web of Science ®Google Scholar
• EBERHARDT W, BEEG T, BECK KF et al.: Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kindney Int. (2000) 57:59–69.
   PubMed Web of Science ®Google Scholar
• UP CHURCH GR, FORD JW, WEISS SJ,MULE JJ, MARLETTA MA, STANLEY JC: Nitric oxide inhibition selectively increases matrix metalloproteinase-9 activation in vitro by rat aortic smooth muscle cells. Surg. Forum (2000) 51:395–397.
   Google Scholar
• KASTAN MB, CANMAN CE, LEONARD CJ: p53 cell cycle control and apoptosis: implication for cancer. Cancer Met. Rev (1995) 14:3–15.
   PubMed Web of Science ®Google Scholar
• NISHIO E, FUKUSHIMA K, SHIOZAKI M, WATANABE Y: Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. Biochem. Biophys. Res. Commun. (1996) 221:163–168.
   PubMedGoogle Scholar
• UMANSKY V, SCHIRRMACHER V: Nitric oxide-induced apoptosis in tumor cells. Adv. Cancer Res. (2001) 82:107–31.
   Google Scholar
• USHMOROV A, RATTER F, LEHMANN V, DROGE W, SCHIRRMACHER V, UMANSKY V: Nitric oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome c release. Blood (1999) 93:2342–2352.
   PubMed Web of Science ®Google Scholar
• XIE K, DONG Z, FIDLER IJ: Activationof nitric oxide synthase gene for inhibition of cancer metastasis. j Leukoc. Biol. (1996) 59:797–803.
   PubMed Web of Science ®Google Scholar
• MOOCHHALA S, CHHATWAL VJS, CHAN STF, NGOI SS, CHIA YW, RAUFF A: Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis (1996) 17:1171–1174.
   PubMed Web of Science ®Google Scholar
• LALA PK, ORUCEVIC A: Significance of nitric oxide in carcinogenesis, tumor progression and cancer therapy. Cancer Metastasis Rev (1998) 17(1):1–6.
   Google Scholar
• ••Excellent and very comprehensive review.
   Google Scholar
• LALA PK, ORUCEVIC A: Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev (1998) 17(1):91–106.
   Google Scholar
• ••Excellent and very comprehensive review.
   Google Scholar
• LALA PK, CHAKRABORTY C: Role of nitric oxide in carcinogenesis and tumor progression. Lancet arca] (2001) 2(3):149–156.
   PubMed Web of Science ®Google Scholar
• ••Excellent and very comprehensive review.
   Google Scholar
• JADESKI LC, CHAKRABORTY C, LALA PK: Role of nitric oxide in tumour progression with special reference to a murine breast cancer model. Canadian Physiol Pharmacol (2002) 80(2):125–135.
   Google Scholar
• BUGA GM, IGNARRO LJ: Nitric oxide and cancer. In: Nitric Oxide. Ignarro LJ (Eds), Academic Press, San Diego (2000):895–920.
   Google Scholar
• ALBINA JE, REICHNER JS: Role of macrophage-derived nitric oxide in target cell injury. In: Nitric Oxide. Ignarro LJ (Eds), Academic Press, San Diego (2000):711–724.
   Google Scholar
• WINK DA, VODOVOTZ Y, LAVAL J, LAVAL E DEWHIRST MW, MITCHELL JB: The multifaceted roles of nitric oxide in cancer. Carcinogenesis (1998) 19(5):711–721.
   PubMed Web of Science ®Google Scholar
• FITZHUGH AL, KEEFER LK: Diazeniumdiolates: Pro- and antioxidant applications of the NONOates'. Free Radical Biol. Med. (2000) 28(10):1463–1469.
   PubMed Web of Science ®Google Scholar
• EANG PG, XIAN M, TANG XP et al.: Nitric oxide donors: chemical activities and biological applications. Chem Rev (2002) 102:1091–1134.
   Google Scholar
• •Excellent and very comprehensive review of NO donors.
   Google Scholar
• JANERO DR: Nitric oxide (NO)-related pharmaceuticals: contemporary approaches to therapeutic NO modulation. Free Radical Biol. Med.(2000) 28(10):1495–1506.
   Google Scholar
• YAMAMOTO T, BING RJ: Nitric oxide donors. Proc. Soc. Esp. Biol. Med. (2000) 225(3):200–206.
   Google Scholar
• LEHMANN J: Nitric oxide donors-current trends in therapeutic applications. Expert Opin. Ther. Patents (2000) 10(5):559–574.
   Web of Science ®Google Scholar
• POTENZA MA, NACCI C, MITOLO-CHIEPPA D: Immunoregulatory effects of L-arginine and therapeutical implications. Cum: Dug Targets: Immune, Endocr. Metab. Disord. (2001) 1(1):67–77.
   PubMedGoogle Scholar
• TAKEMA M, INABA K, UNO K, KAKIHARA K, TAWARA K, MURAMATSU S: Effect of L-arginine on the retention of macrophage tumoricidal activity. j Immunol (1991) 146(6):1928–1933.
   Google Scholar
• WOOD PJ, SANSOM JM, STRATFORD IJ et al.: Changes in energy metabolism and X-ray sensitivity in murine tumors by the nitric oxide donor SIN-1. Br j Cancer (1996) 27(Suppl):5177–5180.
   Google Scholar
• RAMIREZ J, YU L, LI J, BRAUNSCHWEIGER PG, WANG PG: Glyco-Snitrosothiols, a novel class of NO donor compounds. Bioorg. Med. Chem. Lett. (1996) 6:2575–2580.
   Web of Science ®Google Scholar
• HOU YC, JANCZUK A, WANG PG: Current trends in the development of nitric oxide donors. Curr. Pharm. Design (1999) 5:417–441.
   PubMed Web of Science ®Google Scholar
• HOU YC, WANG JQ, RAMIREZ J, WANG PG: Glyco-Snitrosothiols: sugar-SNAP, a new type of nitric oxide donor. Meth. Enzymol. (1999) 301:242–249.
   Google Scholar
• BABICH H, ZUCKERBRAUN HL: In vitro cytotoxicity of glyco-Snitrosothiols. a novel class of nitric oxide donors. Toxicology in vitro. (2001) 15(3):181–190.
   Google Scholar
• CANTUARIA G, MAGALHAES A, ANGIOLO R et al: Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma. Cancer (2000) 88:381–388.
   PubMed Web of Science ®Google Scholar
• HOU YC, WANG JQ, ANDREANA PR etal.: Targeting nitric oxide to cancer cells: cytotoxicity studies of glyco-S-nitrosothiols. Bioorg. Med. Chem. Lett. (1999) 9:2255–2258.
   Google Scholar
• TRIKHA P, SHARMA N, ATHAR M: Nitroglycerin: a NO donor inhibits TPA-mediated tumor promotion in murine skin. Carcinogenesis (2001) 22(8):1207–1211.
   Google Scholar
• ADAMI A, CRIVELLENTE F, CARCERERI A etal.: Biotransformation and cytotoxic properties of NO-donors on MCF7 and U251 cell lines. Life ScL (1998) 63(23):2097–2105.
   Google Scholar
• MARAGOS CM, MORLEY D, WINK DA et a/.: Complexes of.NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. j Med. Chem. (1991) 34(11):3242–3247.
   Google Scholar
• MARAGOS CM, WANG JM, HRABIE JA, OPPENHEIM JJ, KEEFER LK: Nitric oxideinucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res. (1993) 53(3):564–568.
   Google Scholar
• BLACHIER F, BRIAND D, SELAMNIA M, ROBERT V, GUIHOT G, MAYEUR C: Differential inhibitory effects of three nitric oxide donors on ornithine decarboxylase activity in human colon carcinoma cells. Biochem. Pharmacol (1998) 55(8):1235–1239.
   Google Scholar
• BROWN JM: The hypoxic cell: a target for selective cancer therapy-eighteenth. Cancer Res. (1999) 59(23):5863–5870.
   PubMed Web of Science ®Google Scholar
• GRAHAM CH, FORSDIKE J, FITZGERALD CJ, MACDONALD GS: Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int. Cancer (1999) 80(4):617–623.
   PubMed Web of Science ®Google Scholar
• ••First discovery of low doses of NO donorsfor inhibition and prevention of malignant cell phenotypes.
   Google Scholar
• MATTHEWS NE, ADAMS MA, MAXWELL LR, GOFTON TE, GRAHAM CH: Nitric oxide-mediated regulation of chemosensitivity in cancer cells. J. Nat. Cancer Inst. (2001) 93(24):1879–1885.
   PubMedGoogle Scholar
• GATENBY RA, KESSLER HB, ROSENBLUM JS et al.: Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Inter I Rad. arca] Biol. Phys. (1988) 14(5):831–838.
   PubMed Web of Science ®Google Scholar
• JAIN RK: Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev (1990) 9(3):253–266.
   PubMed Web of Science ®Google Scholar
• LIU SM, SUNDQVIST T: Nitric oxide and cGMP regulate endothelial permeability and F-actin distribution in hydrogen peroxide-treated endothelial cells. Exp. Cell. Res. (1997) 235(1):238–244.
   Google Scholar
• BANG L, BOESGAARD S, NIELSEN-KUDSK JE, VEJLSTRUP NG, ALDERSHVILE J: Nitriglycerin-mediated vasorelaxation is modulated by endothelial calcium-activated potassium channels. Cardiovasc. Res. (1999) 43(3):772–778.
   Google Scholar
• ANDRADE SP, BERALDO WT: Pharmacological reactivity of neoplastic and non-neoplastic associated neovasculature to vasoconstrictors. Int. I Exp. Pathol (1998) 79(6):425–432.
   Google Scholar
• MORRIS VL, SCHMIDT EE, KOOP S et al.: Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis. Exp. Cell Res.(1995)219(2) :571–578.
   Google Scholar
• BURCHENAL JH, KALAHER K, DEW K, LOKYS L: Rationale for development of platinum analogs. Cancer Treatment Reports (1979) 63:1493–1498.
   PubMedGoogle Scholar
• BRAUNSCHWEIGER PG, CAMERON D, SHARPE L, ALI-OSMAN F, GRIMM E, BUZAID A: Cisplatin and nitric oxide have synergistic antitumor activity in cP resistant human melanoma cells. Proc. AACR (1996) 37:1865.
   Google Scholar
• AZIZZADEH B, YIP HT, BLACKWELL KE et al.: Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma. Laryngoscope (2001) 111(11):1896–1900.
   Google Scholar
• KIRIKAE T, OJIMA I, MA Z, KIRIKAE HIRAI Y, NAKANO M: Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages. Biochem. Biophys. Res. Commun. (1998) 245:698–704.
   Google Scholar
• KIRIKAE T, OJIMA I, FUERO-ODERDA C et al: Structural significance of the acyl group at the C-10 position and the A ring of the taxane core of paclitaxel for inducing nitric oxide and tumor necrosis factor production by murine macrophages. FEBS Lett. (2000) 478(3):221–226.
   Google Scholar
• BURKHART CA, BERMAN JW, SWINDELL CS, HORWITZ SB: Relationship between the structure of taxol and other taxanes on induction of tumor necrosis factor-a gene expression and cytotoxicity. Cancer Res. (1994) 54(22):5779–5782.
   Google Scholar